[Treatment of nonalcogolic fatty disease of liver].
The experimental and clinical data concerning of treatment of nonalcogolic fatty liver disease (NAFLD) are summarized and analyzed in the review. Some aspects of pathogenetic pharmacotherapy of NAFLD have been discussed (correction of insulin resistance, obesity, dislipidemia, oxidative stress, hepatoprotectors, restoration of intestine microbiosis, replacement hormonal, syndrome and antihypertensive drugs).  Medical and non - medical methods of treatment  is compared. It is concluded that further study to improve methods of prevention and treatment of NAFLD are required.
N A
NA
Antelava
M V
MV
Gongadze
M V
MV
Okudzhava
K Z
KZ
Pachkoriia
M I
MI
Gogolauri
D001835:Body Weight; D005234:Fatty Liver / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007333:Insulin Resistance; D008099:Liver / Q000473:pathology; D065626:Non-alcoholic Fatty Liver Disease; D009765:Obesity / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D018384:Oxidative Stress